expecting HEPLISAV approval by Dec 15th
Short < 10.09 Stop 10.21 Target - 9.75
Hourly chart. Modest breakout from bullish base.
Someone bought 1000 Dec 16 calls on this biotech.
DVAX has broken a key level on 4h chart. I'm expecting more downside, with a potential test on the lower channel. For the long term i'm looking for a breakout to the upside of this channel.
vk.com Left new incentives for growth
Looks to be breaking down here. Target $16
I am bearish